SCImago Journal & Country Rank

Ranking and Indexing

Rank:
Index Copernicus Value (2010): 5.45
CNCSIS B+ (code 820) since 2007

International Databases:
SCOPUS since 2009
EBSCO Academic Search Complete since 2008
Index Copernicus Journals Master List since 2009
Directory of Open Access Journals (DOAJ) since 2008
ProQuest
Genamics JournalSeek since 18/2008

International Catalogues:
Oxford University's Library since 2003

Journal Info

Title: Studia Universitatis Vasile Goldis, Seria Stiintele Vietii (Life Sciences Series)
Abbreviated title: Studia Univ. VG, SSV
Publisher: "Vasile Goldis" University Press
Owner: Western University "Vasile Goldis" Arad, Romania
ISSN: 1584-2363
e-ISSN: 1842-7863
ISSN-L: 1584-2363

Who's Online

We have 152 guests online

Index Databases

Protective effects of silymarin on epirubicin–induced hepatotoxicity in mice Print E-mail
Written by Sasu A., Herman H., Folk A., Balta C., Rosu M, Miutescu E, Hermenean A., Cotoraci C.   
Read full article
Article Title: Protective effects of silymarin on epirubicin–induced hepatotoxicity in mice
Authors: Sasu A., Herman H., Folk A., Balta C., Rosu M, Miutescu E, Hermenean A., Cotoraci C.
Affiliation: 1 Department of Hematology, “Vasile Goldis” Western University of Arad 2 Institute of Life Sciences, “Vasile Goldis” Western University of Arad 3 Department of Pathology, “Vasile Goldis” Western University of Arad 4 Department of Gastroenterology, “Vasile Goldis” Western University of Arad 5 Department of Histology, “Vasile Goldis” Western University of Arad
Abstract: Hepatotoxicity of chemotherapy is frequent, depending upon the chemotherapeutic regimen and individual factors. The anthraciclins hepatotoxicity was studied on laboratory animals and chemotherapy-treated patients, and it showed clinical, biological, structural and ultrastructural changes at hepatic level. The present study aims to evaluate the hepatic toxic effects of epirubicin in mice and to bring scientific proof on the hepatoprotection capacity of silymarin in liver chemotherapy toxicity. We used six mice lots: control, epirubicin (Epi), Epi+ 50mg/kg sylimarin (SM), Epi+100mg/kg SM, 50mg/kg SM and 100mg/kg SM, and we performed biochemical testing of liver markers, and histological analysis of liver tissue. We also looked at epirubicin within the hepatic tissue in darkfield microscopy with hyperspectral detection. The results revealed the increase of alanine aminotransferase, aspartate aminotransferase and gamma glutamyl transferase in epirubicin treated group, which were improved after silymarin treatment. The liver of epirubicin treated mice showed histological abnormalities, and these were also ameliorated by the treatment with silymarin, especially the 100mg/kg dose. The adjuvant hepatoprotector therapies are especially valuable in the prevention and improvement of liver chemotherapy toxicity.
Keywords: epirubicin, hepatotoxicity, chemotherapy, hepatic serum markers, silymarin
*Correspondence: Alciona Sasu, Department of Hematology, “Vasile Goldis” Western University of Arad, Romania. This e-mail address is being protected from spambots. You need JavaScript enabled to view it